Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

ClinicalTrials.gov ID: NCT02986139

Public ClinicalTrials.gov record NCT02986139. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 12:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Crossover Study to Assess the Injection Site Pain Associated With a Modified Etanercept Formulation in Adult Subjects With Either Rheumatoid Arthritis or Psoriatic Arthritis

Study identification

NCT ID
NCT02986139
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
111 participants

Conditions and interventions

Interventions

  • Commercial Formulation Etanercept Drug
  • New Formulation Etanercept Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 28, 2016
Primary completion
Sep 7, 2017
Completion
Oct 8, 2017
Last update posted
Jul 17, 2019

2016 – 2017

United States locations

U.S. sites
29
U.S. states
15
U.S. cities
29
Facility City State ZIP Site status
Research Site Birmingham Alabama 35216
Research Site El Cajon California 92020
Research Site Lomita California 90717
Research Site Sherman Oaks California 91403
Research Site Thousand Oaks California 91320
Research Site Cutler Bay Florida 33157
Research Site DeLand Florida 32720
Research Site Doral Florida 33126
Research Site Largo Florida 33770
Research Site Miami Florida 33165
Research Site Winter Haven Florida 33880
Research Site Quincy Illinois 62301
Research Site Skokie Illinois 60076
Research Site Bay City Michigan 48706
Research Site Grand Rapids Michigan 49546
Research Site Flowood Mississippi 39232
Research Site Kansas City Missouri 64114
Research Site Freehold New Jersey 07728
Research Site Smithtown New York 11787
Research Site Middleburg Heights Ohio 44130
Research Site Wyomissing Pennsylvania 19610
Research Site Orangeburg South Carolina 29118
Research Site Dallas Texas 75231
Research Site El Paso Texas 79935
Research Site Houston Texas 77034
Research Site Mesquite Texas 75150
Research Site The Woodlands Texas 77382
Research Site Bothell Washington 98021
Research Site South Charleston West Virginia 25309

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02986139, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 17, 2019 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02986139 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →